Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
[(3E)-4-(5-ethoxypyridin-3-yl)but-3-en-1-yl](methyl)amine
96) and ten times for the 5-HT2A (pEC50=7
InChi: InChI=1S/C5H5NO2/c7-5(8)4-2-1-3-6-4/h1-3
and AKT phosphorylation and the downstream activation of NF-kappaB in human lung epithelial carcinoma cells (A549) and and human non-small cell lung carcinoma cells (H1299)
(RS)-APICA Size:Contact [email protected] for quotation EZH2 inhibition as a therapeuticProduct information CAS Number: 170847 18 4 Molecular Weight: 257. 18 Formula: C10H12NO5P Chemical Name: (1S) 1 amino 5 phosphono 2,3 dihydro 1H indene 1 carboxylic acid Smiles: N[C@]1(CCC2=CC(=CC=C12)P(O)(O)=O)C(O)=O InChiKey: ZNQZXIHSJUDIKL JTQLQIEISA N InChi: InChI=1S C10H12NO5P c11 10(9(12)13)4 3 6 5 7(17(14,15)16)1 2 8(6)10 h1 2,5H,3 4,11H2,(H,12,13)(H2,14,15,16) t10 m0 s1 Technical Data Appearance: Solid Power Purity: 98% (or refer to the
US$ 375.00
US$ 150.00
US$ 2650.00
US$ 750.00
US$ 160.00
US$ 325.00
US$ 4000.00
US$ 190.00
US$ 130.00
US$ 250.00
US$ 425.00
US$ 610.00